Stock listing

NGM:ABERA Abera Bioscience AB Aktie

Home listing (NGM) of Abera Bioscience AB

Follow Abera Bioscience AB into a list and get an email when it puts out news.

Abera Bioscience AB logo
Ticker
NGM:ABERA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NGM
Currency
SEK

What changed lately

Latest news

ABERA: 7% organic growth and stable margins in Q1 2026, with strong energy and infrastructure demand

May 12, 2026

ABERA: Transition to clinical-stage vaccines, strong financing, and expanded R&D drive future growth

Feb 12, 2026

ABERA: Secured funding and positive R&D milestones drive clinical progress despite ongoing losses

Nov 13, 2025

ABERA: Positive preclinical results and new funding drive clinical trial preparations and liquidity

Aug 21, 2025

ABERA: Positive Q1 2025 result and strong vaccine pipeline progress, supported by grants

May 13, 2025

ABERA: Strong grants and preclinical results position Abera for growth in mucosal vaccines

Feb 13, 2025

ABERA: Q3 2024 saw grant-driven revenue, reduced losses, and pipeline expansion for Abera Bioscience

Nov 13, 2024

ABERA: Net loss narrowed and vaccine pipeline advanced as new lab and funding boosted operations

Aug 21, 2024

All Abera Bioscience AB news

Decks

Abera Bioscience AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
3 in the last 12 months · 8 in all · newest May 12, 2026 · oldest 2024
Decks
1 deck · latest 2026

Where Abera Bioscience AB is listed

ListingExchangeCountryCurrency
NGM:ABERA · Home listing · This pageNGMSwedenSEK
Frankfurt:8WKFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Abera Bioscience AB.